Repare Therapeutics Inc. financial data

Symbol
RPTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
7171 Frederick Banting, Suite 270, Building 2, Saint Laurent, Quebec, Canada
State of incorporation
Canada (Federal Level)
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 668 % +34.7%
Debt-to-equity 17.9 % -41.2%
Return On Equity -31.1 % -2629%
Return On Assets -26.4 % -2918%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42.4M shares +0.83%
Common Stock, Shares, Outstanding 42.4M shares +0.84%
Entity Public Float 383M USD -15.8%
Common Stock, Value, Issued 486M USD +0.75%
Weighted Average Number of Shares Outstanding, Basic 42.4M shares +0.85%
Weighted Average Number of Shares Outstanding, Diluted 42.4M shares +0.85%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 131M USD +3.37%
General and Administrative Expense 33.5M USD +1.09%
Operating Income (Loss) -95.8M USD -1503%
Nonoperating Income (Expense) 12.1M USD +1.82%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -83.7M USD -547%
Income Tax Expense (Benefit) -15.2M USD -169%
Net Income (Loss) Attributable to Parent -68.5M USD -2122%
Earnings Per Share, Basic -1.63 USD/shares -2617%
Earnings Per Share, Diluted -1.64 USD/shares -2633%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 79.8M USD -30.9%
Marketable Securities, Current 128M USD -22.3%
Assets, Current 229M USD -21.7%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 3.23M USD -33.1%
Operating Lease, Right-of-Use Asset 2.2M USD -50.5%
Other Assets, Noncurrent 307K USD -24.8%
Assets 235M USD -22%
Accounts Payable, Current 7.18M USD +46.8%
Employee-related Liabilities, Current 4.38M USD +13.8%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 31.4M USD -40.9%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 218K USD -90.2%
Liabilities 31.7M USD -43.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -134K USD +68.4%
Retained Earnings (Accumulated Deficit) -355M USD -23.9%
Stockholders' Equity Attributable to Parent 204M USD -17%
Liabilities and Equity 235M USD -22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 11.9M USD
Net Cash Provided by (Used in) Financing Activities 375K USD -9.2%
Net Cash Provided by (Used in) Investing Activities -20.3M USD -204%
Common Stock, Shares, Issued 42.4M shares +0.84%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.05M USD +78.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 276M USD -6.13%
Deferred Tax Assets, Valuation Allowance 112M USD +15%
Deferred Tax Assets, Gross 112M USD +15%
Operating Lease, Liability 3.41M USD -37.2%
Depreciation 501K USD +13.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -68.2M USD -1845%
Lessee, Operating Lease, Liability, to be Paid 3.51M USD -38.3%
Property, Plant and Equipment, Gross 11.5M USD +20.2%
Operating Lease, Liability, Current 1.96M USD -15.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.02M USD -57.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.49M USD +6.32%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 102K USD -61.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 957K USD -61.6%
Deferred Tax Assets, Operating Loss Carryforwards 69.9M USD +66.4%
Preferred Stock, Shares Issued 0 shares
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 613K USD +2.34%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 25.7M USD +14.3%